Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Q4 2023 Earnings Conference Call February 27, 2024 4:30 PM ET Company Participants Peter Vozzo - IR Jack Khattar - CEO Tim Dec - CFO Conference Call Participants Andrew Tsai - Jefferies David Amsellem - Piper Sandler Stacy Ku - TD Cowen Jack Padovano - Stifel Operator Good afternoon, and welcome to the Supernus Pharmaceuticals' Fourth Quarter and Full Year 2023 Financial Results Conference Call. [Operator Instructions] As a reminder, this conference call is being ...